☰
Similar researchers to Amy Dunn: Advanced Search
Name Institution Area Added by Date  
Kelly M. Lohr (Info) Emory, Harvard VMAT2, dopamine, Parkinson's disease garymiller 2014‑05‑03 Sim(0.78)
David L. Sulzer (Info) Columbia University Medical School synaptic physiology and cell biology of the basal ganglia in health and disease rfaust 2008‑08‑07 Sim(0.78)
Kristen Ann Stout (Info) Emory VMAT2, dopamine signaling kastout 2013‑01‑21 Sim(0.78)
Alison I. Bernstein (Info) Emory, Michigan State parkinson's disease, vmat2, epigenetics, pesticides, developmental toxicity abernstein 2010‑12‑15 Sim(0.77)
Shawn P. Alter (Info) Emory spalter 2013‑06‑05 Sim(0.76)
Carlie Hoffman (Info) Emory gary.miller@emory.edu 2019‑01‑24 Sim(0.76)
Xiaoxi Zhuang (Info) Chicago Basal Ganglia, dopamine mazen 2007‑03‑06 Sim(0.75)
Tonya N. Taylor (Info) Oxford garymiller 2010‑08‑26 Sim(0.74)
William M. Caudle (Info) Emory dopamine, Parkinsons disease pq 2015‑11‑26 Sim(0.74)
Martin Darvas (Info) University of Washington Dopamine, Learning, Memory MDarvas 2010‑10‑21 Sim(0.73)
W Michael Caudle (Info) University of Washington tsguillot 2008‑05‑12 Sim(0.73)
Thomas S. Guillot (Info) Emory tsguillot 2008‑05‑12 Sim(0.73)
Emmanuel N. Pothos (Info) Tufts Medical School Neuroscience, Pharmacology, Physiology, Obesity diasinou 2006‑10‑28 Sim(0.72)
Raul Gainetdinov (Info) IIT time 2013‑09‑01 Sim(0.72)
Karen S. Rommelfanger (Info) Emory Norepinephrine pq 2015‑10‑05 Sim(0.71)
Stefano Cataldi (Info) Columbia (FlyTree) Parkinson's, Neurochemistry, Microdialysis, Behavior, Neurodegeneration, Neuroscience igortat 2015‑11‑20 Sim(0.71)
Polina Kosillo (Info) Oxford cragg 2018‑11‑14 Sim(0.71)
Penelope Hallett (Info) Harvard Medical School Dstandaert 2018‑11‑17 Sim(0.71)
Katrin Mooslehner (Info) Babraham Institute, Cambridge PiersEmson 2016‑01‑27 Sim(0.7)
Igor Tatarnikov (Info) UBC (FlyTree) Parkinson's, Electrophysiology, Neurodegeneration, Neuroscience igortat 2015‑11‑20 Sim(0.7)
Francesco Longo (Info) NYU CNS fl2018 2018‑11‑20 Sim(0.7)
Anna-Kristin Kaufmann (Info) Oxford Midbrain dopamine system akk 2017‑05‑02 Sim(0.7)
Habibeh Khoshbouei (Info) University of Florida Dopamine Transporter brichardson85 2014‑01‑29 Sim(0.7)
Sarah Threlfell (Info) cbloomfield 2007‑11‑15 Sim(0.7)
Bruno Giros (Info) McGill Molecular Neurobiology, Psychiatry, Neuropsychopharmacology Giros 2013‑03‑12 Sim(0.7)
Kennie Raviie Shepherd (Info) Morehouse School of Medicine garymiller 2010‑08‑26 Sim(0.7)
Katherine Brimblecombe (Info) Oxford cragg 2018‑11‑14 Sim(0.69)
Heather A. Boger (Info) MUSC dopamine, GDNF, Parkinson's disease boger 2008‑11‑07 Sim(0.69)
Thomas S. Hnasko (Info) UCSD, UCSF, University of Washington neurotransmitters, dopamine, glutamate, vesicular transporters, synaptic physiology, addiction tshnasko 2010‑06‑23 Sim(0.69)
Graziella Madeo (Info) NIH/NIDA Parkinson's disease, dopamine, neuroprotection, preclinical model Madeo 2015‑08‑25 Sim(0.69)
Stephen G. Rayport (Info) Columbia DA/GLU Cotransmission, VTA, SN dopaminechoi 2008‑07‑18 Sim(0.68)
Mickael Decressac (Info) Lund University Parkinson's disease mdecressac 2012‑01‑14 Sim(0.68)
Sandra Dovero (Info) Université de Bordeaux Neurodegenerative disorders erwan 2008‑06‑11 Sim(0.68)
Nicola Biagio Mercuri (Info) Tor Vergata University, Roma, Italy- IRCCS Santa Lucia Foundation Dopamine and Basal Ganglia mercurin 2017‑01‑14 Sim(0.68)
Oleh Hornykiewicz (Info) University of Vienna Dopamine, Parkinson's Disease pezawas 2008‑06‑08 Sim(0.68)
Ofelia M. Littrell (Info) University of Kentucky pq 2015‑10‑08 Sim(0.68)
Senthilkumar S. Karuppagounder (Info) Johns Hopkins Medical School, Auburn University, Jadavpur University, Indian inst. of Chemical Engineering Parkinson's Disease, Neurodegeneration, Synaptic Transmission, hippocampal glutamatergic system, AMPA and NMDA channels pq 2015‑10‑14 Sim(0.68)
Jason R. Richardson (Info) Florida International tsguillot 2008‑05‑12 Sim(0.68)
Rosario Moratalla (Info) Cajal Institute, CSIC, Madrid Parkinson disease, drug abuse, dyskinesia moratalla 2015‑11‑26 Sim(0.67)
Greg Gerhardt (Info) University of Kentucky KevinPang 2007‑05‑03 Sim(0.67)
Wayne A. Cass (Info) University of Kentucky kfrogg 2008‑12‑04 Sim(0.67)
Roger Cachope (Info) CHDI Foundation Huntington's Disease, Dopamine, Endocannabinoids, Synaptic plasticity, Schizophrenia rcachope 2010‑02‑17 Sim(0.67)
Jonathan P. Britt (Info) NIDA Drug Abuse jonbritt 2010‑09‑22 Sim(0.67)
Deniz Kirik (Info) Lund University Parkinson's Disease, Disease models TomasB 2010‑03‑19 Sim(0.67)
John D. Elsworth (Info) Yale Dopamine Dysfunction basseterre 2013‑07‑25 Sim(0.67)
Robert Henry Roth (Info) Yale Neuropsychopharmacology djentsch 2006‑10‑27 Sim(0.67)
Michael F. Salvatore (Info) University of North Texas Health Science Center at Fort Worth kfrogg 2008‑12‑04 Sim(0.67)
Alexander F. Hoffman (Info) NIDA Intramural Research Program cannabinoids, cocaine, electrophysiology, addiction uchsc99 2016‑05‑04 Sim(0.66)
Rachel Cliburn (Info) Notre Dame gary.miller@emory.edu 2019‑01‑24 Sim(0.66)
Rachel Cliburn (Info) Notre Dame gary.miller@emory.edu 2019‑01‑24 Sim(0.66)
Sign in to add a new person